TY - JOUR T1 - Variation in practice remains in the UK management of varicella postexposure prophylaxis in children with cancer JF - Archives of Disease in Childhood JO - Arch Dis Child SP - 101 LP - 101 DO - 10.1136/archdischild-2018-315362 VL - 104 IS - 1 AU - Katharine Jarrold AU - Jessica Bate Y1 - 2019/01/01 UR - http://adc.bmj.com/content/104/1/101.2.abstract N2 - Exposure to varicella and its potential to cause significant morbidity and treatment delays remain a concern in children with cancer. In 2002, national guidance introduced oral aciclovir as an alternative form of varicella postexposure prophylaxis (PEP) to varicella zoster immunoglobulin (VZIG), as recommended by Public Health England (PHE).1 2 A survey of UK paediatric oncology centres identified almost half of children requiring PEP receive VZIG while the remainder receive oral aciclovir, motivated by unit preference and anecdotal experience.3 An online survey was distributed to all 21 UK paediatric oncology centres in February 2018 to … ER -